Home › Lupus › District of Columbia
Lupus clinical trials in District of Columbia
5 studies for Lupus are looking for participants at sites in District of Columbia.
Cities in District of Columbia
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Washington D.C.
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 30, 2026 · NCT05835310Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
- Children's National Health System, Washington D.C.
RecruitingObservational study
Ages 5 to 21 · All sexes · Updated Jul 24, 2026 · NCT04833465Lupus Landmark Study: A Prospective Registry and Biorepository
- Georgetown University, Washington D.C.
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Apr 15, 2026 · NCT05934149Research Accelerated by You Lupus Registry
- Online Registry - No Physical Site Required, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated Jan 23, 2026 · NCT06927219From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.